Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-04

Clinical Trial Update: Darbepoetin Administration to Preterm Infants [Phase 2]

View source ↗

Summary

Phase 2 study evaluating darbepoetin alfa administration in preterm infants has completed, with results posted in February 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: University of New Mexico | Conditions: Infant, Newborn | Phase 2 | Status: COMPLETED | Results posted: 2019-02-04